(pharmalive.com): Wolters Kluwer Pharma Solutions, Inc. has published the collective recommendations of an international team of healthcare experts on how payers can improve their risk-sharing approaches for expensive new therapies and technology. Participants of the 2009 Banff Summit on evidence development, held in Calgary, Canada, reached a consensus about how to better evaluate and design payer reimbursement mechanisms for high-cost medical treatments. Participants included leading risk-sharing experts from Australia, Canada, the U.K. and the U.S., all who were signatories on a consensus statement. The resulting guidelines were published for the first time in the Adis journal PharmacoEconomics.
Category: Articles
Click here